RESEARCH TRIANGLE PARK, N.C. — Talecris Biotherapeutics has selected Siemens to provide its information technology infrastructure services.
The multi-year contract is worth $69 million.
RTP-based Talecris discovers, develops and produces treatments for a variety of disorders in immunology, pulmonology and hemostasis. Talecris was formed in April 2005 around the Bayer Biological Products’ plasma business.
“To support Talecris’ leadership in developing and delivering global protein therapies, we felt Siemens Business Services, Inc. was our clear partner of choice to provide high quality, reliable, flexible service our customers and business demand,” said Jim Engle, vice president of information technology for Talecris. “By utilizing the benefits of their SieQuence solution, we can better leverage our entrepreneurial spirit, our innovative technologies, state-of-the-art facilities and our IT talent for continued competitive advantage.”
SieQuence is a package of integrated services designed to meet a client’s IT and business plan needs.